Para-Methoxy Cinnamaldehyde

Para-Methoxy Cinnamaldehyde

SCHEMBL1226375

C=CC=O.COc1ccc(C=CC=O)cc1

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.53
CYP2A6 P11509 1/20 0.53
KDM4E B2RXH2 3/20 0.52
LMNA P02545 2/20 0.52
CYP3A4 P08684 2/20 0.52
TP53 P04637 1/20 0.52
TSHR P16473 1/20 0.52
TRPA1 O75762 1/20 0.50
F3 P13726 1/20 0.50
RELA Q04206 1/20 0.50
THRB P10828 1/20 0.49
ATM Q13315 1/20 0.49
ESR1 P03372 2/20 0.48
CYP1A2 P05177 2/20 0.48
ABL1 P00519 1/20 0.48
TTR P02766 1/20 0.48
CYP1A1 P04798 1/20 0.48
ABCB1 P08183 1/20 0.48
ALOX5 P09917 1/20 0.48
BCR P11274 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Para-Methoxy Cinnamaldehyde SCHEMBL547945 0.92 ALDH1A1 (0.61) ALDH1A1CYP2A6KDM4ELMNACYP3A4
Para-Methoxy Cinnamaldehyde SCHEMBL1046275 0.92 ALDH1A1 (0.61) ALDH1A1CYP2A6KDM4ELMNACYP3A4
Para-Methoxy Cinnamaldehyde SCHEMBL514958 0.92 ALDH1A1 (0.61) ALDH1A1CYP2A6KDM4ELMNACYP3A4
SCHEMBL27725906 0.87 HDAC8 (0.59) ALDH1A1CYP2A6KDM4ELMNACYP3A4
SCHEMBL11876953 0.85 ALDH1A1 (0.57) ALDH1A1CYP2A6KDM4ELMNACYP3A4
SCHEMBL566691 0.85 ALDH1A1 (0.57) ALDH1A1CYP2A6KDM4ELMNACYP3A4
SCHEMBL11875760 0.85 ALDH1A1 (0.57) ALDH1A1CYP2A6KDM4ELMNACYP3A4
SCHEMBL11875764 0.85 ALDH1A1 (0.57) ALDH1A1CYP2A6KDM4ELMNACYP3A4
SCHEMBL566692 0.85 ALDH1A1 (0.57) ALDH1A1CYP2A6KDM4ELMNACYP3A4
SCHEMBL11876949 0.85 ALDH1A1 (0.57) ALDH1A1CYP2A6KDM4ELMNACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2459727-A2 BIOCATALYST FOR CATALYTIC HYDROAMINATION BASF SE (DE) 2012-06-06 EP disclosed
US-20120123155-A1 BIOCATALYST FOR CATALYTIC HYDROAMINATION BASF SE (DE) 2012-05-17 US disclosed
WO-2011012632-A2 BIOCATALYST FOR CATALYTIC HYDROAMINATION BASF SE (DE) 2011-02-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120123155-A1 BIOCATALYST FOR CATALYTIC HYDROAMINATION HDHD5, PAH, GRHPR ALDH1A1 783/4885CYP2A6 1439/4885KDM4E 2889/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.